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The ability of epithelial cells and endothelial cells to transform
into mesenchymal cells is one of the most basic cellular
mechanisms in biology.This process, referred to as epithelial-
mesenchymal transition (EMT) or endothelial-mesenchymal
transition (EndMT), regulates various stages of embryonic
development and contributes to the progression of a wide
array of diseases and in tissue repair [1, 2].
During embryogenesis, EMT is essential for gastrulation,
primitive streak formation, somite dissociation, neural crest
development, and palate and lip fusion [3]. EndMT is critical
for cardiac development, particularly in the formation of
the valves and septa of the heart [4] and the generation of
mesodermal cells and multipotent progenitors [5].
In the adult organism, EMT and EndMT are usually
dormant until pathological stimuli awaken this embryonic
mechanism. For example, EMT is the primary mechanism
of cancer metastasis [6, 7], whereas EndMT forms cancer-
associated fibroblasts in the tumor microenvironment [8].
Also, both EMT and EndMT have been shown to generate
fibroblasts that cause the formation of scar tissue after tissue
injury or in association with inflammatory and fibrotic
diseases [9–11].
Mesenchymal transitions have traditionally been consid-
ered to have a positive effect in development and a negative
effect in disease. However, novel findings regarding the stem
cell phenotype generated by EMT andEndMT [12, 13] suggest
that they may have therapeutic potential for the treatment of
various degenerative diseases. This marks an exciting period
in this field of research, which may provide new methods for
tissue engineering and regeneration by harnessing the power
of this embryonic mechanism.
In this special issue, the articles focus on the cutting-
edge research on EMT/EndMT, including the role of this
mechanism in regenerative medicine, peritoneal fibrosis,
liver fibrosis, systemic sclerosis, and angiogenesis. This issue
also explores how factors such as mechanical force, vitamin
D signaling, and noncoding RNAs regulate mesenchymal
transitions, which may provide novel insight into future
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